Current Assets
Restricted Cash
Vertex Pharmaceuticals Restricted Cash increased by 300.0% to $12.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 12.1%, from $10.70M to $12.00M. Over 5 years (FY 2020 to FY 2025), Restricted Cash shows an upward trend with a 33.8% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryLiquidity
SignalContext dependent
VolatilityStable
First reportedQ4 2014
Last reportedQ1 2026May 5, 2026
How to read this metric
An increase may signal higher debt service requirements or increased collateral obligations, while a decrease may indicate the release of restricted funds.
Detailed definition
Cash balances that are legally or contractually set aside for specific purposes, such as debt service reserves, collater...
Peer comparison
Common in capital-intensive industries like energy where project financing requires specific reserve accounts.
Metric ID:
restricted_cashHistorical Data
19 periods
| Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.50M | $5.10M | $3.90M | $1.90M | $5.50M | $8.00M | $5.70M | $2.30M | $6.40M | $3.20M | $11.40M | $10.90M | $8.90M | $2.60M | $10.70M | $9.80M | $8.20M | $3.00M | $12.00M |
| QoQ Change | — | +13.3% | -23.5% | -51.3% | +189.5% | +45.5% | -28.7% | -59.6% | +178.3% | -50.0% | +256.3% | -4.4% | -18.3% | -70.8% | +311.5% | -8.4% | -16.3% | -63.4% | +300.0% |
| YoY Change | — | — | — | — | +22.2% | +56.9% | +46.2% | +21.1% | +16.4% | -60.0% | +100.0% | +373.9% | +39.1% | -18.8% | -6.1% | -10.1% | -7.9% | +15.4% | +12.1% |
Range$1.90M – $12.00M
CAGR+24.4%
Avg YoY Growth+40.0%
Median YoY Growth+16.4%
Restricted Cash at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's restricted cash?
- Vertex Pharmaceuticals (VRTX) reported restricted cash of $12.00M in Q1 2026.
- How has Vertex Pharmaceuticals's restricted cash changed year-over-year?
- Vertex Pharmaceuticals's restricted cash increased by 12.1% year-over-year, from $10.70M to $12.00M.
- What is the long-term trend for Vertex Pharmaceuticals's restricted cash?
- Over 5 years (2020 to 2025), Vertex Pharmaceuticals's restricted cash has grown at a 33.8% compound annual growth rate (CAGR), from $700.00K to $3.00M.
- What does restricted cash mean?
- Cash that is legally tied up and cannot be used for day-to-day operations.